Citations

Showing 10 of 107850 citations.

A fusion pore phenotype in mast cells of the ruby-eye mouse
Fernández, Julio M. , Oberhauser, Andrés F.

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 93 | Issue: 25 | Pages: 14349-14354

10.1073/pnas.93.25.14349 | PMID 8962054 Get It

Using patch-clamp capacitance and amperometric techniques, we have identified an exocytotic phenotype that affects the function of the fusion pore, the molecular structure that connects the lumen of a secretory vesicle with the extracellular environment during exocytosis. Direct observation of individual exocytotic events in mast cells from the ruby-eye mouse ( ru / ru ) showed a 3-fold increase in the fraction and duration of transient fusion events with respect to wild-type mice. The fraction of the total fusion events that were transient increased from 0.22 ± 0.02 (wild type) to 0.65 ± 0.02 ( ru / ru ), and the average duration of these events increased from 418 ± 32 ms (wild type) to 1207 ± 89 ms ( ru / ru ). We also show that this phenotype can reduce and delay an evoked secretory response by causing the fusion of vesicles that have been previously emptied by repeated cycles of transient fusion. The exocytotic phenotype that we describe here may be a cause of diseases like platelet storage pool deficiency and prolonged bleeding times for which the ruby-eye mouse serves as an animal model. Furthermore, the identification of the gene causing the fusion pore phenotype reported here will illuminate the molecular mechanisms regulating exocytotic fusion.
Carbon monoxide and nitric oxide as coneurotransmitters in the enteric nervous system: Evidence from genomic deletion of biosynthetic enzymes
Xue, L., Farrugia, Gianrico , Miller, Steven M. , Ferris, C D, Snyder, Solomon H. , Szurszewski, Joseph H., Xue, L.

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 97 | Issue: 4 | Pages: 1851-1855

10.1073/pnas.97.4.1851 | PMID 10677545 Get It

Nitric oxide (NO) and carbon monoxide (CO) seem to be neurotransmitters in the brain. The colocalization of their respective biosynthetic enzymes, neuronal NO synthase (nNOS) and heme oxygenase-2 (HO2), in enteric neurons and altered intestinal function in mice with genomic deletion of the enzymes ( nNOS Δ/Δ and HO2 Δ/Δ ) suggest neurotransmitter roles for NO and CO in the enteric nervous system. We now establish that NO and CO are both neurotransmitters that interact as cotransmitters. Small intestinal smooth muscle cells from nNOS Δ/Δ and HO2 Δ/Δ mice are depolarized, with apparent additive effects in the double knockouts ( HO2 Δ/Δ / nNOS Δ/Δ ). Muscle relaxation and inhibitory neurotransmission are reduced in the mutant mice. In HO2 Δ/Δ preparations, responses to electrical field stimulation are nearly abolished despite persistent nNOS expression, whereas exogenous CO restores normal responses, indicating that the NO system does not function in the absence of CO generation.
Serum choline activates mutant acetylcholine receptors that cause slow channel congenital myasthenic syndromes
Zhou, Ming, Engel, Andrew G. , Auerbach, Anthony

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 96 | Issue: 18 | Pages: 10466-10471

10.1073/pnas.96.18.10466 | PMID 10468632 Get It

We have found that mutant acetylcholine receptor channels (AChRs) that cause slow-channel congenital myasthenic syndromes are activated by serum and that the high frequency of openings in serum is reduced by treatment with choline oxidase. Thus, slow-channel congenital myasthenic syndrome AChRs at the neuromuscular junction are likely to be activated both by steady exposure to serum choline and by transient exposure to synaptically released transmitter. Single-channel kinetic analyses indicate that the increased response to choline is caused by a reduced intrinsic stability of the closed channel. The results suggest that a mutation that destabilizes the inactive conformation of the AChR, together with the sustained exposure of endplates to serum choline, results in continuous channel activity that contributes to the pathophysiology of the disease.
Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets
Naumov, Yuri N., Bahjat, Keith S., Gausling, Rudolph, Abraham, Roshini S. , Exley, Mark A. , Koezuka, Yasuhiko, Balk, Steven B., Strominger, Jack L. , Clare-Salzer, Michael, Wilson, S. Brian

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 98 | Issue: 24 | Pages: 13838-13843

10.1073/pnas.251531798 | PMID 11707602 Get It

CD1d-restricted invariant NKT (iNKT) cells are immunoregulatory cells whose loss exacerbates diabetes in nonobese diabetic (NOD) female mice. Here, we show that the relative numbers of iNKT cells from the pancreatic islets of NOD mice decrease at the time of conversion from peri-insulitis to invasive insulitis and diabetes. Conversely, NOD male mice who have a low incidence of diabetes showed an increased frequency of iNKT cells. Moreover, administration of α-galactosylceramide, a potent activating ligand presented by CD1d, ameliorated the development of diabetes in NOD female mice and resulted in the accumulation of iNKT cells and myeloid dendritic cells (DC) in pancreatic lymph nodes (PLN), but not in inguinal lymph nodes. Strikingly, injection of NOD female mice with myeloid DC isolated from the PLN, but not those from the inguinal lymph nodes, completely prevented diabetes. Thus, the immunoregulatory role of iNKT cells is manifested by the recruitment of tolerogenic myeloid DC to the PLN and the inhibition of ongoing autoimmune inflammation.
Effect of age on in vivo rates of mitochondrial protein synthesis in human skeletal muscle
Rooyackers, Olav , Adey, Deborah , Ades, Philip A. , Nair, K. Sreekumaran

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 93 | Issue: 26 | Pages: 15364-15369

10.1073/pnas.93.26.15364 | PMID 8986817 Get It

A progressive decline in muscle performance in the rapidly expanding aging population is causing a dramatic increase in disability and health care costs. A decrease in muscle endurance capacity due to mitochondrial decay likely contributes to this decline in muscle performance. We developed a novel stable isotope technique to measure in vivo rates of mitochondrial protein synthesis in human skeletal muscle using needle biopsy samples and applied this technique to elucidate a potential mechanism for the age-related decline in the mitochondrial content and function of skeletal muscle. The fractional rate of muscle mitochondrial protein synthesis in young humans (24 ± 1 year) was 0.081 ± 0.004%·h −1 , and this rate declined to 0.047 ± 0.005%·h −1 by middle age (54 ± 1 year; P < 0.01). No further decline in the rate of mitochondrial protein synthesis (0.051 ± 0.004%·h −1 ) occurred with advancing age (73 ± 2 years). The mitochondrial synthesis rate was about 95% higher than that of mixed protein in the young, whereas it was approximately 35% higher in the middle-aged and elderly subjects. In addition, decreasing activities of mitochondrial enzymes were observed in muscle homogenates (cytochrome c oxidase and citrate synthase) and in isolated mitochondria (citrate synthase) with increasing age, indicating declines in muscle oxidative capacity and mitochondrial function, respectively. The decrease in the rates of mitochondrial protein synthesis is likely to be responsible for this decline in muscle oxidative capacity and mitochondrial function. These changes in muscle mitochondrial protein metabolism may contribute to the age-related decline in aerobic capacity and muscle performance.
Generating an idea: will it be publishable?
Sarr, M. G.

Mayo Clinic

Journal of British Surgery | July 26, 2002 | Volume: 87 | Issue: 4 | Pages: 388-389

10.1046/j.1365-2168.2000.01434.x | PMID 10759727 Get It

Vibro-acoustography: An imaging modality based on ultrasound-stimulated acoustic emission
Greenleaf, James F. , Fatemi, Mostafa

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 96 | Issue: 12 | Pages: 6603-6608

10.1073/pnas.96.12.6603 | PMID 10359758 Get It

We describe theoretical principles of an imaging modality that uses the acoustic response of an object to a highly localized dynamic radiation force of an ultrasound field. In this method, named ultrasound-stimulated vibro-acoustography (USVA), ultrasound is used to exert a low-frequency (in kHz range) force on the object. In response, a portion of the object vibrates sinusoidally in a pattern determined by its viscoelastic properties. The acoustic emission field resulting from object vibration is detected and used to form an image that represents both the ultrasonic and low-frequency (kHz range) mechanical characteristics of the object. We report the relation between the emitted acoustic field and the incident ultrasonic pressure field in terms of object parameters. Also, we present the point-spread function of the imaging system. The experimental images in this report have a resolution of about 700 μm, high contrast, and high signal-to-noise ratio. USVA is sensitive enough to detect object motions on the order of nanometers. Possible applications include medical imaging and material evaluation.
Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation
Rinaldo, Piero, Rhead, William J., Tian, Liqun, Millington, David S., Vockley, Jerry , Hamm, Doug A., Brix, Amy E., Lindsey, J. Russell, Pinkert, Carl A. , O’Brien, William E., Kurtz, David M. , Wood, Philip A.

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 95 | Issue: 26 | Pages: 15592-15597

10.1073/pnas.95.26.15592 | PMID 9861014 Get It

Abnormalities of fatty acid metabolism are recognized to play a significant role in human disease, but the mechanisms remain poorly understood. Long-chain acyl-CoA dehydrogenase (LCAD) catalyzes the initial step in mitochondrial fatty acid oxidation (FAO). We produced a mouse model of LCAD deficiency with severely impaired FAO. Matings between LCAD +/− mice yielded an abnormally low number of LCAD +/− and −/− offspring, indicating frequent gestational loss. LCAD −/− mice that reached birth appeared normal, but had severely reduced fasting tolerance with hepatic and cardiac lipidosis, hypoglycemia, elevated serum free fatty acids, and nonketotic dicarboxylic aciduria. Approximately 10% of adult LCAD −/− males developed cardiomyopathy, and sudden death was observed in 4 of 75 LCAD −/− mice. These results demonstrate the crucial roles of mitochondrial FAO and LCAD in vivo .
Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunized with fusions of dendritic and carcinoma cells
Chen, Dongshu, Kashiwaba, Masahiro , Li, Yongqing , Takeuchi, Hideya , Qu, Hui , Rowse, Gerald J., Gendler, Sandra , Küfe, Donald , Gong, Jianlin , Chen, Ling

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 95 | Issue: 11 | Pages: 6279-6283

10.1073/pnas.95.11.6279 | PMID 9600956 Get It

Immunological unresponsiveness established by the elimination or anergy of self-reactive lymphocyte clones is of importance to immunization against tumor-associated antigens. In this study, we have investigated induction of immunity against the human MUC1 carcinoma-associated antigen in MUC1 transgenic mice unresponsive to MUC1 antigen. Immunization of adult MUC1 transgenic mice with irradiated MUC1-positive tumor cells was unsuccessful in reversing unresponsiveness to MUC1. By contrast, fusions of dendritic cells with MUC1-positive tumor cells induced cellular and humoral immunity against MUC1. Immunization with the dendritic cell fusions that express MUC1 resulted in the rejection of established metastases and no apparent autoimmunity against normal tissues. These findings demonstrate that unresponsiveness to the MUC1 tumor-associated antigen is reversible by immunization with heterokaryons of dendritic cells and MUC1-positive carcinoma cells.
Bronchial asthma: Lessons from murine models
Gleich, G.J., Kita, Hirohito , Kita, H

Mayo Clinic

Proceedings of the National Academy of Sciences | July 26, 2002 | Volume: 94 | Issue: 6 | Pages: 2101-2102

10.1073/pnas.94.6.2101 | PMID 9122154 Get It